2026年11月3日星期二
M
Hoàn Vũ Thông Giám
Tin nhanh toàn cầu
Oriental Kopi founder wants to put Malaysia on the menu— 日经 Nikkei AsiaIndonesian political maneuvers hinder market reforms amid downgrade threats— 日经 Nikkei AsiaChinese Communist Party taps big data surveillance to combat corruption— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaMyanmar refugees fill labor gaps in Thailand as Cambodians return home— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaOriental Kopi founder wants to put Malaysia on the menu— 日经 Nikkei AsiaIndonesian political maneuvers hinder market reforms amid downgrade threats— 日经 Nikkei AsiaChinese Communist Party taps big data surveillance to combat corruption— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaMyanmar refugees fill labor gaps in Thailand as Cambodians return home— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

Nguồn Nature 医学研究21 giờ trước
Tóm tắt nội dung

Trang này chỉ cung cấp tiêu đề và chỉ mục tóm tắt, toàn bộ nội dung và bản quyền đều thuộc về bên phát hành gốc, vui lòng nhấp vào liên kết gốc để đọc.

Đi tới bài gốc
Kênh trực thuộc
Sức khỏe
Khu vực trực thuộc
Góc nhìn toàn cầu
Ngôn ngữ gốc
English
Số mục
health-00a74bed

Comments 0 comments

No comments yet. Be the first.

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials · Hoàn Vũ Thông Giám